ClinicalTrials.Veeva

Menu

Hyperinflammation and Hyperferritinemia in Critically Ill Patients (HYFER)

C

Charles University, Czech Republic

Status

Not yet enrolling

Conditions

Hyperinflammatory Syndrome
Critical Illness
Hyperferritinemia
Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT06820905
HYFER_2025

Details and patient eligibility

About

Analysing trajectory of critically ill patients with signs of hyperinflammation

Enrollment

1,962 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • critically ill patients
  • admission between 01.01.2020 and 31.12.2024 (5yrs)

Exclusion criteria

  • none

Trial design

1,962 participants in 1 patient group

critically ill patients
Description:
critically ill patients admitted to ICU between 01.01.2020 and 31.12.2024

Trial contacts and locations

1

Loading...

Central trial contact

Thomas Karvunidis, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems